All News

The approval makes enzalutamide the first and only androgen receptor-signaling inhibitor approved for the treatment of nonmetastatic castration-sensitive prostate cancer with biochemical recurrence at high risk for metastatic.

Capivasertib is indicated for hormone receptor-positive, human epidermal growth factor 2-negative locally advanced or metastatic breast cancer with 1 or more PIK3CA/ALT1/PTEN-alterations.

Not only is the test significant for identifying HIV and TB, but it can be safer for patients living with HIV due to their suppressed immune systems.

The legal and common uses of “interchangeability” continue to be conflated.

In this multi-part series on burnout and the problems currently facing pharmacy, trauma-informed pharmacist Helen Sairany, PharmD, MBA, discusses why burnout is skyrocketing.

In human heart tissues, investigators found that the mechanism associated with heart failure can be reversed and Dicer activity can be restored when AD-9308 was used.

The products include Doxycycline Hyclate Delayed-Release Tablets, Lisdexamfetamine Dimesylate Capsules, Calcium Gluconate in Sodium Chloride Injection, Estradiol Tablets USP

Older treatments and novel options are changing the way obesity is treated and managed

Lisa Deschamps, CEO of AviadoBio, discusses frontotemporal dementia and AVB-101, a one-time therapy designed to stop disease progression by delivering a functional copy of the GRN gene and restoring progranulin levels in the brain.

The approval marks the first authorized at-home sample collection test for sexually transmitted diseases.

In addition to language barriers, pharmacy translation software errors may cause further complications when filling patient prescriptions.

While manganese can sometimes be considered toxic, prenatal exposure may be linked to better memory at adolescence.

Repotrectinib is a tyrosine kinase inhibitor (TKI) that targets ROS1 and is administered as an oral therapy for treatment of locally advanced or metastatic ROS1-positive non–small cell lung cancer.

The study also found that 82% of the surveyed physicians reported not getting labs to help determine treatment options for their patients.

A single infusion of VERVE-101, a gene editing tool, improved both blood PCSK9 protein levels and blood LDL-C levels in 10 individuals with high-risk HeFH.

The RESCUE BT2 trial sheds further light on the agent’s potential.

The products include Crovalimab, Dapagliflozin, Secukinumab, Roflumilast

This interstate agreement can empower pharmacists to respond to large-scale emergencies

Expert discusses changes health care professionals should know about drug coverage and out-of-pocket costs through the IRA

The approval marks the sixth cancer type PD-L1 IHC 22C3 pharmDx has been granted, and the first for GEJ

Taurolidine and heparin (Defencath; CorMedix) is indicated to reduce catheter-related bloodstream infections for adults with kidney failure who are receiving chronic hemodialysis via central venous catheter

The approval will benefit patients who have difficulty swallowing, dysphagia, or high taste sensitivities and struggle to adhere to the original antibiotic.

The genes that predispose a person to sleep problems can impact that person across their entire lifetime, so interventions targeted toward a younger audience could be beneficial.

Researchers provided recommendations based on the current status of COVID-19 infection and role of therapies.

The business model took time to catch up to pharmacy’s potential, and community-based patient care leads the way

Acne is one of the most common conditions, with about 50 million Americans dealing with acne annually.

Session speaker Powell-Wiley explains how screening for SDOH in patients as cardiovascular-kidney-metabolic syndrome stages progress can help better understand their individual social needs.

The products include Reserve Sleep Gummies, Menopause Stage Indicator, Organic Ashwagandha Gummies, and Precise Pain Relieving Cream.

The drug may be a risk factor for dementia-related illnesses.

In this episode, you'll hear a conversation with Ron Lanton, partner at Lanton Law, who gets us up to speed on all of the legal cases surrounding this issue thus far.